[Back to Issue S1 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]

REVIEW: Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase

Ekaterina S. Vinogradova1, Oleg S. Nikonov1, and Ekaterina Yu. Nikonova1,a*

1Institute of Protein Research, 142290 Pushchino, Moscow Region, Russia

* To whom correspondence should be addressed.

Received September 4, 2020; Revised September 29, 2020; Accepted October 6, 2020
Aminoacyl-RNA synthetases (aaRSs) are among the key enzymes of protein biosynthesis. They are responsible for conducting the first step in the protein biosynthesis, namely attaching amino acids to the corresponding tRNA molecules both in cytoplasm and mitochondria. More and more research demonstrates that mutations in the genes encoding aaRSs lead to the development of various neurodegenerative diseases, such as incurable Charcot–Marie–Tooth disease (CMT) and distal spinal muscular atrophy. Some mutations result in the loss of tRNA aminoacylation activity, while other mutants retain their classical enzyme activity. In the latter case, disease manifestations are associated with additional neuron-specific functions of aaRSs. At present, seven aaRSs (GlyRS, TyrRS, AlaRS, HisRS, TrpRS, MetRS, and LysRS) are known to be involved in the CMT etiology with glycyl-tRNA synthetase (GlyRS) being the most studied of them.

DOI: 10.1134/S0006297921140029